Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, par value $0.00001
-
Shares outstanding
-
62,162,717
-
Total 13F shares
-
141,826
-
Share change
-
-86,075
-
Total reported value
-
$12,303,055
-
Price per share
-
$87.34
-
Number of holders
-
23
-
Value change
-
-$6,016,419
-
Number of buys
-
12
-
Number of sells
-
5
Institutional Holders of Protagonist Therapeutics, Inc - Common Stock, par value $0.00001 (PTGX) as of Q4 2025
As of 31 Dec 2025,
Protagonist Therapeutics, Inc - Common Stock, par value $0.00001 (PTGX) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
141,826 shares.
The largest 10 holders included
EXCHANGE TRADED CONCEPTS, LLC, Louisiana State Employees Retirement System, SG Americas Securities, LLC, YOUSIF CAPITAL MANAGEMENT, LLC, FRANKLIN STREET ADVISORS INC /NC, Cache Advisors, LLC, Palumbo Wealth Management LLC, Allspring Global Investments Holdings, LLC, NISA INVESTMENT ADVISORS, LLC, and WEALTH ENHANCEMENT ADVISORY SERVICES, LLC.
This page lists
23
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.